Table 2. Cervical cancer screening coverage at baseline, those referring a private gynecologist and rescued coverage post intervention and final population coverage attained by intervention and age groups.
Age group | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
<40 | 40–49 | 50–59 | ≥60 | |||||||||||||||||||||
IG1 | IG2 | IG3 | IG1 | IG2 | IG3 | IG1 | IG2 | IG3 | IG1 | IG2 | IG3 | |||||||||||||
N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
TARGET POPULATION | 3156 | 100 | 2775 | 100 | 3643 | 100 | 2376 | 100 | 2107 | 100 | 2705 | 100 | 1677 | 100 | 1824 | 100 | 2263 | 100 | 1295 | 100 | 1136 | 100 | 1787 | 100 |
BASELINE COVERAGE | 1862 | 59.0 | 1647 | 59.4 | 1939 | 53.2 | 1343 | 56.5 | 1260 | 59.8 | 1204 | 44.5 | 977 | 58.3 | 1131 | 62.0 | 1158 | 51.2 | 589 | 45.5 | 530 | 46.7 | 638 | 35.7 |
STUDY TARGET | 1294 | 41.0 | 1128 | 40.6 | 1704 | 46.8 | 1033 | 43.5 | 847 | 40.2 | 1501 | 55.5 | 700 | 41.7 | 693 | 38.0 | 1105 | 48.8 | 706 | 54.5 | 606 | 53.3 | 1149 | 64.3 |
RESCUED | 449 | 14.2 | 392 | 14.1 | 576 | 15.8 | 512 | 21.5 | 381 | 18.1 | 665 | 24.6 | 314 | 18.7 | 318 | 17.4 | 584 | 25.8 | 303 | 23.4 | 276 | 24.3 | 571 | 32.0 |
PRIVATE SCREENING | 415 | 13.1 | 266 | 9.6 | 625 | 17.2 | 172 | 7.2 | 164 | 7.78 | 451 | 16.7 | 89 | 5.3 | 104 | 5.7 | 173 | 7.6 | 102 | 7.9 | 115 | 10.1 | 186 | 10.4 |
LOST TO FOLLOW UP | 430 | 41.0 | 470 | 16.9 | 503 | 13.8 | 349 | 14.7 | 302 | 14.3 | 385 | 14.2 | 297 | 17.7 | 271 | 14.9 | 348 | 15.4 | 301 | 23.2 | 215 | 18.9 | 392 | 21.9 |
FINAL COVERAGE | 3002 | 95.1 | 2557 | 92.1 | 3551 | 97.5 | 1904 | 80.1 | 1717 | 81.5 | 2178 | 80.5 | 1389 | 82.8 | 1568 | 86.0 | 1903 | 84.1 | 832 | 64.2 | 742 | 65.3 | 1138 | 63.7 |
p-value heterogeneity IG1-IG2-IG3 | 0.554 | 0.029 | 0.001 | 0.001 |